Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Medicover’s results presentation for Q2 2023

Medicover’s (MCOV B ) Q2 report 2023 will be published on 26 July at 07.45 CEST. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST. The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session. Shortly before the webcast, presentation slides will be available on medicover.com . To access live webcast register here . To dial in and ask questions

Introducing AskGamblers Casino Reviews: Your Trusted Source for Unbiased Insights

July 17, 2023 - In the fast-paced online gambling world, finding a reliable and trustworthy casino can be daunting. With countless options available, how can you be sure you're making the right choice? That's where AskGamblers Casino Reviews step in. Our comprehensive and insightful reviews provide all the information you need to make an informed decision and enjoy a top-notch gaming experience.Why are online casino reviews important? They offer a window into the world of online casinos, allowing you to gauge the quality of gaming and bonus offers, the level of security, the efficiency of

YIT to build office, sales and warehouse project for SBA Urban in Vilnius, Lithuania

YIT Corporation Press Release 17 July 2023 at 10:00 a.m.YIT to build office, sales and warehouse project for SBA Urban in Vilnius, Lithuania YIT and SBA Urban, a Lithuanian real estate development and investment company have signed a general contract for the construction of the office, sales and warehouse project Urban HUB in Lithuanian capital Vilnius. The value of the contract is approximately EUR 23 million, and it will be recorded in the order book for the third quarter of 2023. The construction works are planned to be started in July 2023 and the project is scheduled to be completed

Publishing of Caverion’s Half-year Financial Report for January−June 2023 on 3 August 2023

Caverion Corporation Investor News 17 July 2023 at 10.00 a.m. EESTPublishing of Caverion’s Half-year Financial Report for January−June 2023 on 3 August 2023 Caverion Corporation’s Half-year Financial Report for January−June 2023 will be published on Thursday, 3 August 2023, at approximately 8:00 a.m. (Finnish Time, EEST). The stock exchange release and presentation materials in Finnish and in English will be published at that time on the company's website at www.caverion.com/investors. News conference for investors and media Caverion will hold a news conference on the Half-year

Sensys Gatso receives an order from North Africa worth SEK 8,7 million

Sensys Gatso Group, a global leader in traffic safety systems, through its subsidiary Sensys Gatso Netherlands, has received an order for in-vehicle based traffic enforcement systems spare parts worth EUR 754 thousand, corresponding to SEK 8,7 million, from North Africa.This order is for the delivery of in-vehicle speed enforcement spare parts and is a continuation of the project that Sensys Gatso Group started in 2015. The order is planned to be delivered during the second half of 2023. The use of our unique in-vehicle systems has proven to be a very effective way to enforce speed and

In Aptahem’s FIH study further analytic studies will be performed

Aptahem AB (publ), a biotech company developing treatments for patients suffering from acute inflammatory diseases such as sepsis, announces today that in the double-blinded randomized placebo controlled first-in-human (FIH) clinical trial further analytic studies on the mechanism of Apta-1 are recommended which will result in a temporary hold of the study.During the course of the study, additional analyses have been performed, which indicated interesting findings. After reviewing the data, the Data Review Committee concluded that further assays would be recommended. Aptahem are using this

Atlas Copco completes acquisition of Korean cryopump service provider and distributor

Nacka, Sweden, July 17, 2023: Atlas Copco has completed the acquisition of the cryopump service and distribution business of ZEUS Co., Ltd. The business provides service and sales distribution for the Vacuum Technique business area’s CTI and Polycold products in South Korea.The seller of the business, ZEUS Co., Ltd (ZEUS), is a company listed on the KOSDAQ Korea Exchange. The business unit that Atlas Copco is acquiring from ZEUS is located in Gyeonggi-do, south of Seoul, and has 59 employees. In 2021, the business had revenues of approximately BKRW 15 (MSEK 119*). The CTI and Polycold

Nurminen Logistics Oyj - Managers' Transactions

Nurminen Logistics Plc                    Stock Exchange Release         July 17, 2023, at 9.30. a.m. Person subject to the notification requirement Name: JUHA NURMINENPosition: Member of the Board/Deputy member Issuer: NURMINEN LOGISTICS OYJLEI: 743700O69NCHTNEV0362Notification type: INITIAL NOTIFICATION Reference number: 35597/5/6 Transaction date: 2023-07-13Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHARE ISIN: FI0009900187Nature of transaction: DISPOSAL Transaction details(1)    : Volume: 336 Unit price: 1.025 EUR(2)    : Volume: 125 Unit price: 1.

Wulff Group Plc’s Half-Year Financial Report for January 1 – June 30, 2022

Strong second quarter - investments in sales culture and synergies are paying off 1.4.–30.6.2023 BRIEFLY · Net sales totalled EUR 24.4 million (24.9), decreased by 2.0% · EBITDA and comparable EBITDA was EUR 1.3 million (1.0) · Operating profit and comparable operating profit (EBIT) were EUR 0.8 million (0.4) · Earnings and comparable earnings per share (EPS) were EUR 0.09 (0.02) · The equity ratio was 42.1% (38.8) · The outlook remains unchanged; Wulff estimates that net sales and comparable operating profit 2023 will increase compared to 2022. 1.1.–30.6.2023

ArcticZymes Technologies appoints new CEO

(Tromsø 17 July 2023) ArcticZymes Technologies ASA (OSE:AZT) is pleased to announce the appointment of Michael Akoh as its new Chief Executive Officer.Michael is an accomplished business executive with strong leadership experience, and an established reputation in the life sciences sector. He has over 20+ years of international experience in general management, business development and commercialization within the biopharma industry, including senior roles at diagnostic, med tech and CRO companies. Michael holds a BSc. (Econ) and a MSc. in International Marketing and Management from the

Invitation to a press and analyst conference call for the presentation of Concentric’s Second Quarter 2023 Report

Concentric's Interim Report for Q2 2023 (January-June 2023), will be published on the 26 of July 2023, at 08.00 CET. At 10.00 CET media, investors and analysts are invited to participate/join via webcast/telephone conference for a presentation of the report. President & CEO Martin Kunz and CFO Marcus Whitehouse will host the presentation, which will be held in English and is followed by a Q&A-session. We look forward to your participation. Please see the below detailed information to join in: Press and analysts conference at 10.00 CET (09:00 UK TIME) 1. Access the webcast:

Handelsbanken’s Interim Report for January – June 2023 will be presented Wednesday 19 July

Handelsbanken publishes its interim report for January ­– June 2023, at 07:00 a.m. CET Wednesday, 19 July. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. The President and Group Chief Executive Officer Carina Åkerström will present the interim report at 09:00 a.m. CET. The presentation will be broadcast live in Swedish and available at handelsbanken.com/ir and with the option for simultaneous interpretation into English. The presentation will be followed by a short break, after which a Q&A session will be held in English for analysts, investors

Esmaeilzadeh Holding publishes net asset value as of 30 June 2023

As of 30 June 2023, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 7.89 billion (SEK 8.15 billion as of 31 May 2023), corresponding to a net asset value per share of SEK 10,240 (SEK 10,568 as of 31 May 2023). For further information, please contact: Saeid Esmaeilzadeh, CEO and founder saeid@ehab.group Nils Fredrik Lagerstrand, General Counsel & Deputy CEO +46 720 90 26 99, nilsfredrik@ehab.group The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 17 July 2023. About Esmaeilzadeh Holding

Comments regarding Esmaeilzadeh Holding’s net asset value as of 30 June 2023

Esmaeilzadeh Holding AB (publ) (”EHAB”) today published its net asset value as of 30 June 2023. To provide further details on the changes compared to the previously published net asset value, EHAB is including comments below regarding two of the holdings in its portfolio. As of 30 June 2023, EHAB’s fair value of its holding in Rebellion Capital AB (”Rebellion”) amounts to SEK 1,012.1 million (SEK 1,082.1 million as of 31 May 2023). The adjusted fair value is based on the valuation used in the implementation of a new incentive program in Rebellion during the second quarter of 2023.As of

Peab company receives frame contract for housing project in Stockholm

Smidmek AB, a company in the Peab Group, has been commissioned to undertake a frame contract for the construction of rental apartments on Södermalm in Stockholm. The customer is Stockholmshem and the contract is worth SEK 143 million.The project comprises 151 rental apartments, a preschool, assisted living and shops in the city block Persikan on eastern Södermalm in central Stockholm. In total the residential block comprises 1,240 apartments, most of which are ready to move into now. Smidmek’s part of the contract is clearly delineated and mounting includes filigree plates, columns,

SAGAX INVESTS SEK 1,110 MILLION

Sagax has entered into an agreement with Hedin Mobility Group regarding a sale- and leaseback transaction concerning 16 properties located in the Netherlands (7 properties), Belgium (8 properties) and Germany (1 property). In connection with the closing, Hedin Mobility Group will enter into long-term triple-net lease agreements for all properties.   Hedin Mobility Group is one of Europe’s largest vehicle distributers and retailers with over SEK 50 billion in turnover and 180,000 sold vehicles during 2022. Hedin Mobility Group has more than 8,000 employees and 270 facilities in 7

Precedential US Federal Court Decision Hands SNIPR Biome a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing

· Five contested patents held by SNIPR remain in place  · Precedential ruling means that SNIPR’s patent portfolio will not be subject to any further interference and will not be judged by the old first-to-invent standardCopenhagen, July 17[th] 2023: SNIPR Biome ApS, the company pioneering CRISPR-based microbial gene therapy, announces today the United States Court of Appeals for the Federal Circuit has issued a precedential ruling in favor of SNIPR in a patent interference case with Rockefeller University.   The patent interference case focused on one allowed patent application

H&M to enter Brazil

Today, H&M announces plans to launch its stores and online in Brazil during 2025. H&M continues its expansion in Latin America by initially entering major cities in Southeast Brazil with a view to further increase its presence across the country over time.  H&M opened its first store in Latin America in Mexico in 2012, and today is also present in Peru, Uruguay, Chile, Colombia, Ecuador, Guatemala, Panama, and Costa Rica. With a population of over 210 million in Brazil and a strong appreciation for fashion, there is considerable potential for expansion in the market.  “We are thrilled

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 17 July 2023 at 9:00 EESTDuring the 1–30 June 2023 conversion period there were six conversions and a total of 570 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 17 July 2023, and trading in the new R shares will start on 18 July 2023.Breakdown of shares after conversion:A shares     176,233,727R shares     612,386,260Total           788,619,987Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237,472,353.For further information,

Notice of extraordinary general meeting of the shareholders in Readly International AB (publ) to be held on 10 August 2023

The shareholders of Readly International AB (publ), reg. no. 556912-9553, (the “Company” or “Readly”), are hereby called to an extraordinary general meeting to be held on Thursday 10 August 2023 at 10.00 (CEST), at the Company’s premises at Kungsgatan 17 in Stockholm. Entry and registration begin at 09.30 (CEST).The board of directors has decided, pursuant to the Company’s articles of association, that shareholders shall have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the meeting by attending in person,

DNB Bank ASA shall buy back up to 1.5 percent of the company’s own shares

The Board of Directors of DNB Bank ASA has decided to initiate a share buy-back programme comprising up to 1.5 percent of the company’s own shares, which represents a total of 23,139,197 shares. The buy-back programme was adopted based on an authorisation given by the Annual General Meeting held on 25 April 2023. The Financial Supervisory Authority of Norway has approved the buy-back programme, on the condition that the total buy-backs do not reduce the company’s own funds by more than NOK 4.9 billion. The purpose of the buy-back programme is to optimise the company’s capital structure,

Resilience in the Construction Industry: Embracing Opportunities for Long-Term Goals and Sustainable Development

The construction industry has always faced its fair share of challenges, but the past few years have been particularly demanding. From economic downturns to global pandemics, the industry has experienced turbulence that has tested its resilience. However, amidst these tenuous times, there lies a significant opportunity for those with a long-term vision and products that align with future development and sustainability goals. By embracing resilience and adapting to changing circumstances, the construction industry can survive and thrive in the face of adversity.Navigating Turbulence In

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

· Favorable safety profile and effective biochemical control in 52-week trial · Significant improvement of acromegaly symptoms vs. standard of care at baseline · Improved patient reported treatment satisfaction, convenience, and quality of life Lund, Sweden — 17 July 2023 — Camurus (NASDAQ STO: CAMX) today announced topline, interim data from an open-label, long-term safety and extension trial, ACROINNOVA 2, assessing CAM2029, octreotide subcutaneous (SC) depot, in 135 adult patients with acromegaly. These include both new patients and roll-over patients from the previous

Lucara Provides Karowe Underground Expansion Project Update

VANCOUVER, BC, July 16, 2023 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) provides an update on the Karowe Underground Expansion project (the “UGP”). The Karowe UGP is designed to access the highest value portion of the Karowe orebody, extend mine life to at least 2040 and deliver approximately $4 billion in additional revenues using conservative diamond price assumptions which are un-escalated and exclude exceptional stone revenues.   Management initiated an update to the UGP schedule and budget in response to slower than

There are no items matching the current filter
There are no more items matching the current filter
Back to top